Showing results (1181-1190 of 13,969) with videos related to

Sort By:
Pageof 1,397
Frontiers in Cardiovascular Medicine|December 27, 2021
Development and Validation of a Prediction Model for Irreversible Worsened Cardiac Function in Patients With Acute Decompensated Heart FailureLei Wang, Yun-Tao Zhao
Frontiers in Cardiovascular Medicine|August 29, 2022
Combining electrocardiographic criteria for predicting acute total left main coronary artery occlusionChunwei Liu, Fan Yang, Yuecheng Hu, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Progress in murine models of ruptured abdominal aortic aneurysmLi Yin, Eric William Kent, Bowen Wang
Frontiers in Cardiovascular Medicine|August 29, 2022
Hypertension in Women: A South-Asian PerspectiveFatima Farrukh, Amin Abbasi, Misbah Jawed, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Development of hydrogen sulfide donors for anti-atherosclerosis therapeutics research: Challenges and future prioritiesYe-Wei Yang, Nian-Hua Deng, Kai-Jiang Tian, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
The MELD-XI score predicts 3-year mortality in patients with chronic heart failureZebin Lin, Xia Liu, Li Xiao, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
The clinical outcomes of reni-angiotensin system inhibitors for patients after transcatheter aortic valve replacement: A systematic review and meta-analysisShuai Wang, Xiaoxiao Lin, Yihong Guan, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Influence of left ventricular unloading on pediatric post-cardiotomy veno-arterial extracorporeal life support outcomesPaolo Meani, Roberto Lorusso, Mariusz Kowalewski, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Sodium-glucose co-transporter-2 inhibitors reduce the risk of new-onset stroke in patients with type 2 diabetes: A population-based cohort studyTsung-Kun Lin, Yong-Hsin Chen, Jing-Yang Huang, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Maintenance of recovered dilated cardiomyopathy patients with half-dose neurohumoral blockades (MED-CHARM): A protocol for an open-label, pilot, randomized trialPengda Li, Xiaolin Luo, Changchun Hou, et al.
Pageof 1,397